MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

13 DECEMBER 2017

Biom’up to be included in the Euronext’s CAC® Small, CAC® Mid & Small and CAC® All-Tradable indexes 

Saint-Priest, France, December 13, 2017 – Biom’Up, specialist in surgical hemostasis, announces today that, as of Monday December 18, 2017, it will be included in three new CAC-family indexes: CAC® Small, CAC® Mid & Small and CAC® All-Tradable.
The inclusion of Biom’Up shares in these indexes follows an analysis of the share by Euronext based on its free float market cap, and illustrates investor interest in Biom’Up, which recently reached a crucial milestone in its FDA approval process with the positive outcome of the inspection of the production facilities on Biom’up’s Saint Priest site by of the American Food & Drug Administration (FDA).
The Euronext Paris Indexes’ Scientific Committee took this decision during its quarterly review of these indexes on December 7, 2017.

Read more:

pr-13-12-17

ALL NEWS

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.